Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects
Status:
Completed
Trial end date:
2019-11-11
Target enrollment:
Participant gender:
Summary
The study evaluates the safety, tolerability and pharmacokinetics of single and repeated
doses of topical AB001 patch and the bioavailability relative to the oral capsule and topical
positive comparative patch.